Suchergebnisse - "Serry-Bangura, Alimamy"

PubPharm (8)

1

Immunogenicity and Vaccine Shedding After 1 or 2 Doses of rVSVΔG-ZEBOV-GP Ebola Vaccine (ERVEBO®) : Results From a Phase 2, Randomized, Placebo-controlled Trial in Children and Adults

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2024

von Lee, A. | Liu, K. | Lhomme, E. | +130

2

Application of Transthoracic Echocardiography for Cardiac Safety Evaluation in the Clinical Development Process of Vaccines Against Streptococcus pyogenes

enthalten in: Drugs in R&D | 2024

von Nakakana, U. | Serry-Bangura, A. | Edem, B. | +6

3

Application of Transthoracic Echocardiography for Cardiac Safety Evaluation in the Clinical Development Process of Vaccines Against Streptococcus pyogenes

enthalten in: Drugs in R & D | 2024

von Nakakana, U. | Serry-Bangura, A. | Edem, B. | +6

4

Immune response of a two-dose heterologous Ebola vaccine regimen : summary of three African clinical trials using a single validated Filovirus Animal Nonclinical Group enzyme-linked immunosorbent assay in a single accredited laboratory

enthalten in: EBioMedicine | 2023

von McLean, C. | Barry, H. | Kieh, M. | +24

5

Asymptomatic Malaria Infection and the Immune Response to the 2-Dose Ad26.ZEBOV, MVA-BN-Filo Ebola Vaccine Regimen in Adults and Children

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2022

von Ishola, D. | EBOVAC-Salone Malaria Infection (MALI) Sub-Study Team | Bah, O. | +39

6

Ebola Virus Glycoprotein IgG Seroprevalence in Community Previously Affected by Ebola, Sierra Leone

enthalten in: Emerging infectious diseases | 2022

von Manno, D. | Ayieko, P. | Ishola, D. | +21

7

Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone : a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trial

enthalten in: The Lancet. Infectious diseases | 2022

von Ishola, D. | Manno, D. | Afolabi, M. | +132

ErratumIn: Lancet Infect Dis. 2023 Sep;23(9):e337. - PMID 37506728

8

Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone : a randomised, double-blind, controlled trial

enthalten in: The Lancet. Infectious diseases | 2022

von Afolabi, M. | Ishola, D. | Manno, D. | +132

1
[1]